Conclusion: The Imperative of a Resilient, Patient-Centric CRO
avatar - PVR
Julian Galluzzo
Profile
July 28, 2021
-
6
min read

Webinar 'Why Sponsors Are Expanding Clinical Trials to CEE & MENA'

Join the first live webinar in PVR’s new series of industry-focused online events.

On 14 May, we will discuss why more sponsors are expanding clinical trials to CEE and MENA to benefit from faster enrollment, high-quality data, and more efficient study budgets.

During the webinar, we will cover:
● Overview of the current clinical trials landscape in CEE and MENA
● Time and cost comparisons between the US and Western Europe vs target regions
● Data quality insights, including FDA inspection outcomes
● Site activation timelines and opportunities for faster patient enrollment
● Regulatory guidance, including EU CTR and national ethics committees
● Case studies of biotech sponsors successfully expanding clinical trials to CEE and MENA
● Examples of conducting studies in complex environments, including conflict zones  

SPEAKERS:
Vitaliy Solskyy, MD, PhD
Chief Scientific Officer

Clinical research executive with 23 years of experience in drug development, including 16 years in leadership roles across global CROs such as Fortrea/Covance, Chiltern and Parexel. He brings extensive expertise in clinical development strategy, study design, and execution of complex international programs across multiple therapeutic areas. Dr. Solskyy is a trained OB/GYN physician with a PhD in gynecological endocrinology and author of more than 40 scientific publications.

Ramunas Marciulionis
Head of Clinical Operations

Clinical research executive with extensive experience in managing clinical trials and leading teams within the CROs such as Covance/Labcorp/Fortrea and pharmaceutical companies such as Prizer, Eli Lilly, Abbvie. He specializes in clinical operations, projects oversight, and ensuring high-quality study delivery across international environments. Throughout his career, he has held leadership roles focused on improving processes, mentoring teams, and driving operational excellence.
MODERATOR:
Samuel Gal Alterovich, Chairman of the Board

Date: 14 May 2026
Time: 10 AM EDT New York | 4 PM CEST

Register to learn how expanding to CEE and MENA can support faster recruitment, high-quality data, and efficient clinical trial delivery.
Register for the webinar: https://forms.gle/Fw8wU8bcAWCTs6mf7